Antimicrobial pharmacodynamics of vancomycin and disulfiram (Antabuse®) in Staphylococcus aureus
IntroductionIntravenous vancomycin (VAN) is the primary treatment for systemic infections due to methicillin-resistant Staphylococcus aureus (MRSA). Pharmacokinetic/pharmacodynamic target (PK/PD) indices for VAN therapies are more difficult to achieve for MRSA isolates with a minimum inhibitory conc...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2023-01-01
|
| シリーズ: | Frontiers in Microbiology |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.1092257/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|